Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”

Figure 1

Figure 3(b) from Miranda-Hernandez et al. 2016 [1]. Glycan heterogeneity by HILI-UPLC of Infinitam (c) and the reference product (a, b, d). Chromatograms have been labelled (a–d) for this letter.